Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(17%)
Results Posted
100%(3 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_2
2
33%
Ph phase_4
2
33%
Ph phase_3
1
17%
Ph not_applicable
1
17%

Phase Distribution

0

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
2(33.3%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(3)
Terminated(2)

Detailed Status

Completed3
Withdrawn1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (33.3%)
Phase 31 (16.7%)
Phase 42 (33.3%)
N/A1 (16.7%)

Trials by Status

withdrawn117%
completed350%
recruiting117%
terminated117%

Recent Activity

1 active trials
Showing 5 of 6
recruitingphase_4

The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma

NCT05702944
completedphase_4

Phenoxybenzamine Versus Doxazosin in PCC Patients

NCT01379898
completedphase_3

Preoperative Alpha Blockade for Pheochromocytoma

NCT03176693
terminatednot_applicable

Use of Phenoxybenzamine [PBZ] IV to Assist High Flow Low Pressure Perfusion [HFLPP] on Cardio-pulmonary Bypass

NCT00620945
withdrawnphase_2

Parenteral Phenoxybenzamine During Congenital Heart Disease Surgery

NCT00770705
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05702944Phase 4

The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma

Recruiting
NCT01379898Phase 4

Phenoxybenzamine Versus Doxazosin in PCC Patients

Completed
NCT03176693Phase 3

Preoperative Alpha Blockade for Pheochromocytoma

Completed
NCT00620945Not Applicable

Use of Phenoxybenzamine [PBZ] IV to Assist High Flow Low Pressure Perfusion [HFLPP] on Cardio-pulmonary Bypass

Terminated
NCT00770705Phase 2

Parenteral Phenoxybenzamine During Congenital Heart Disease Surgery

Withdrawn
NCT00569855Phase 2

Intravenous Phenoxybenzamine Use in Pediatric Patients Undergoing Open-Heart Surgery

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6